Aphria Inc. (TSX: APH) (OTC: APHQF) announced this morning that the company has received a license amendment from Health Canada that will provide Aphria with an additional 200,000 square feet of cannabis grow space, which will allow the company to complete Part III expansion of its facility in Leamington, Ontario.
The expansion of the Leamington facility triples the Aphria’s production capacity of medical grade cannabis from 9,000 kg annually to 30,000 kg annually.
When Aphria completely expands the facility in Ontario, the company will have over 1,000,000 sq. ft. of production space to grow cannabis at their disposal. Along with their partnerships with Broken Coast Cannabis and Double Diamond Farms, Aphria is anticipating their production capacity to become over 230,00 kg a year.
Aphria is ramping up production ahead of the expected legalization of recreational cannabis in Canada this year, as well, as to expand to international markets.
You may be interested
MedMen Begins Construction of Cannabis Cultivation and Manufacturing Facility in CaliforniaSam Rosenberg - May 24, 2018
Med Men Enterprises has begun construction on a large scale cultivation and manufacturing facility in Desert Hot Springs, California. The new facility is expected to become operational…
Canopy Growth Corp. to Begin Trading on New York Stock Exchange TodaySam Rosenberg - May 24, 2018
Canopy Growth Corporation (TSX: WEED) announced this morning that the company is expected to begin trading on the New York Stock Exchange (NYSE) this morning under the ticker…
Colorado Passes Bill to Allow Public Companies to Invest into Cannabis BusinessesSam Rosenberg - May 23, 2018
Colorado has just passed a House Bill 18-1011 which will allow publicly trade companies in the U.S. to invest and hold medicinal or recreational cannabis cultivation, processing,…